{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:56:31Z","timestamp":1790459791407,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515012364"],"award-info":[{"award-number":["2022A1515012364"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02204-2","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:07:33Z","timestamp":1772096853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria and diabetic kidney disease in adult type 2 diabetes: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanling","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yintong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xubin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"2204_CR1","doi-asserted-by":"crossref","unstructured":"KDIGO. 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117-s314.","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"15","key":"2204_CR2","doi-asserted-by":"publisher","first-page":"8198","DOI":"10.3390\/ijms23158198","volume":"23","author":"S Di Mauro","year":"2022","unstructured":"Di Mauro S, Scamporrino A, Filippello A, Di Marco M, Di Martino MT, Scionti F, et al. Mitochondrial RNAs as potential biomarkers of functional impairment in diabetic kidney disease. Int J Mol Sci. 2022;23(15):8198.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2204_CR3","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","volume":"64","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, et al. Diabetic kidney disease: a report from an ADA consensus conference. Am J Kidney Dis. 2014;64(4):510\u201333.","journal-title":"Am J Kidney Dis"},{"key":"2204_CR4","doi-asserted-by":"publisher","first-page":"723502","DOI":"10.3389\/fendo.2021.723502","volume":"12","author":"JS Fel\u00edcio","year":"2021","unstructured":"Fel\u00edcio JS, de Rider Britto HA, Cortez PC, de Souza Resende F, de Lemos MN, de Moraes LV, et al. Association between 25(OH)Vitamin D, HbA1c and Albuminuria in diabetes mellitus: data from a population-based study (VIDAMAZON). Front Endocrinol (Lausanne). 2021;12:723502.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2204_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2337\/dc17-1144","volume":"42","author":"N Laiteerapong","year":"2019","unstructured":"Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu JY, Huang ES, et al. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (the diabetes & aging study). Diabetes Care. 2019;42(3):416\u201326.","journal-title":"Diabetes Care"},{"issue":"8","key":"2204_CR6","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc17-0636","volume":"40","author":"RW Beck","year":"2017","unstructured":"Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The Fallacy of average: how using HbA(1c) alone to assess glycemic control can Be misleading. Diabetes Care. 2017;40(8):994\u20139.","journal-title":"Diabetes Care"},{"issue":"8","key":"2204_CR7","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593\u2013603.","journal-title":"Diabetes Care"},{"issue":"5","key":"2204_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4093\/dmj.2021.0256","volume":"45","author":"JH Yoo","year":"2021","unstructured":"Yoo JH, Kim JH. Time in range from continuous glucose monitoring: a novel metric for glycemic control. Diabetes Metab J. 2021;45(5):795.","journal-title":"Diabetes Metab J"},{"issue":"5","key":"2204_CR9","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/CM9.0000000000002582","volume":"136","author":"J Wan","year":"2023","unstructured":"Wan J, Lu J, Li C, Ma X, Zhou J. Research progress in the application of time in range: more than a percentage. Chin Med J (Engl). 2023;136(5):522\u20137.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"2204_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/dia.2023.0380","volume":"26","author":"RW Beck","year":"2024","unstructured":"Beck RW, Raghinaru D, Calhoun P, Bergenstal RM. A comparison of continuous glucose monitoring-measured time-in-range 70\u2013180 mg\/dL versus time-in-tight-range 70\u2013140 mg\/dL. Diabetes Technol Ther. 2024;26(3):151\u20135.","journal-title":"Diabetes Technol Ther"},{"issue":"14","key":"2204_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681\u20137.","journal-title":"JAMA"},{"issue":"1","key":"2204_CR12","doi-asserted-by":"publisher","first-page":"e000991","DOI":"10.1136\/bmjdrc-2019-000991","volume":"8","author":"L Mayeda","year":"2020","unstructured":"Mayeda L, Katz R, Ahmad I, Bansal N, Batacchi Z, Hirsch IB, et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease. BMJ Open Diabetes Res Care. 2020;8(1):e000991.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"2204_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.2337\/dc18-1444","volume":"42","author":"RW Beck","year":"2019","unstructured":"Beck RW, Bergenstal RM, Riddlesworth TD, Kollman C, Li Z, Brown AS, et al. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care. 2019;42(3):400\u20135.","journal-title":"Diabetes Care"},{"issue":"8","key":"2204_CR14","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00125-024-06171-y","volume":"67","author":"J De Meulemeester","year":"2024","unstructured":"De Meulemeester J, Charleer S, Visser MM, De Block C, Mathieu C, Gillard P. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia. 2024;67(8):1527\u201335.","journal-title":"Diabetologia"},{"key":"2204_CR15","doi-asserted-by":"publisher","first-page":"112325","DOI":"10.1016\/j.diabres.2025.112325","volume":"226","author":"JY Kim","year":"2025","unstructured":"Kim JY, Kim S, Park SH, Lee JA, Cho SH, Oh R, et al. Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: a cross-sectional study. Diabetes Res Clin Pract. 2025;226:112325.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"2204_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137\u201347.","journal-title":"Ann Intern Med"},{"key":"2204_CR17","doi-asserted-by":"publisher","first-page":"112189","DOI":"10.1016\/j.diabres.2025.112189","volume":"224","author":"M Di Marco","year":"2025","unstructured":"Di Marco M, Scilletta S, Miano N, Capuccio S, Musmeci M, Di Mauro S, et al. Triglycerides to high density lipoprotein cholesterol ratio (TG\/HDL), but not triglycerides and glucose product (TyG) index, is associated with arterial stiffness in prediabetes. Diabetes Res Clin Pract. 2025;224:112189.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2204_CR18","doi-asserted-by":"publisher","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","volume":"107","author":"M Yapanis","year":"2022","unstructured":"Yapanis M, James S, Craig ME, O\u2019Neal D, Ekinci EI. Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring. J Clin Endocrinol Metab. 2022;107(6):e2221\u201336.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2204_CR19","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2337\/dc18-1131","volume":"41","author":"J Lu","year":"2018","unstructured":"Lu J, Ma X, Zhou J, Zhang L, Mo Y, Ying L, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care. 2018;41(11):2370\u20136.","journal-title":"Diabetes Care"},{"issue":"10","key":"2204_CR20","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1089\/dia.2019.0499","volume":"22","author":"JH Yoo","year":"2020","unstructured":"Yoo JH, Choi MS, Ahn J, Park SW, Kim Y, Hur KY, et al. Association between continuous glucose monitoring-derived time in range, other core metrics, and albuminuria in type 2 diabetes. Diabetes Technol Ther. 2020;22(10):768\u201376.","journal-title":"Diabetes Technol Ther"},{"key":"2204_CR21","doi-asserted-by":"publisher","first-page":"5817074","DOI":"10.1155\/2020\/5817074","volume":"2020","author":"Q Guo","year":"2020","unstructured":"Guo Q, Zang P, Xu S, Song W, Zhang Z, Liu C, et al. Time in range, as a novel metric of glycemic control, is reversely associated with presence of diabetic cardiovascular autonomic neuropathy independent of HbA1c in Chinese type 2 diabetes. J Diabetes Res. 2020;2020:5817074.","journal-title":"J Diabetes Res"},{"issue":"7","key":"2204_CR22","first-page":"558","volume":"27","author":"B Lobo","year":"2025","unstructured":"Lobo B, Kanapka L, Kovatchev BP, Kollman C, Beck RW. The association of time-in-range and time-in-tight-range with retinopathy progression in the virtual diabetes control and complications trial continuous glucose monitoring dataset. Diabetes Technol Ther. 2025;27(7):558\u201361.","journal-title":"Diabetes Technol Ther"},{"issue":"Supplement1","key":"2204_CR23","first-page":"S20","volume":"47","author":"ADAPP Committee","year":"2023","unstructured":"Committee ADAPP. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2023;47(Supplement1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"2","key":"2204_CR24","doi-asserted-by":"publisher","first-page":"101616","DOI":"10.1016\/j.diabet.2025.101616","volume":"51","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Xiao S, Zou F, Jiao X, Shen Y. Continuous glucose monitoring\u2013derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes. Diabetes Metab. 2025;51(2):101616.","journal-title":"Diabetes Metab"},{"issue":"8","key":"2204_CR25","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.2337\/dc14-2898","volume":"38","author":"IB Hirsch","year":"2015","unstructured":"Hirsch IB. Glycemic variability and diabetes complications: Does it matter? Of Course It Does! Diabetes Care. 2015;38(8):1610\u20134.","journal-title":"Diabetes Care"},{"issue":"12","key":"2204_CR26","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2204_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pcad.2025.05.008","volume":"92","author":"G Bosco","year":"2025","unstructured":"Bosco G, Di Giacomo Barbagallo F, Di Marco M, Scilletta S, Miano N, Esposto S, et al. Effect of inclisiran on lipid and mechanical vascular profiles in familial hypercholesterolemia subjects: results from a single lipid center real-world experience. Prog Cardiovasc Dis. 2025;92:108\u201317.","journal-title":"Prog Cardiovasc Dis"},{"issue":"18","key":"2204_CR28","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, Kudva YC, et al. Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med. 2019;381(18):1707\u201317.","journal-title":"N Engl J Med"},{"issue":"6","key":"2204_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa2107519","volume":"385","author":"JP Fr\u00edas","year":"2021","unstructured":"Fr\u00edas JP, Davies MJ, Rosenstock J, P\u00e9rez Manghi FC, Fern\u00e1ndez Land\u00f3 L, Bergman BK, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503\u201315.","journal-title":"N Engl J Med"},{"issue":"5","key":"2204_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2337\/dci23-0092","volume":"47","author":"V Hamidi","year":"2024","unstructured":"Hamidi V, Pettus JH. Time in tight range for patients with type 1 diabetes: The time is now, or is it too Soon? Diabetes Care. 2024;47(5):782\u20134.","journal-title":"Diabetes Care"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02204-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02204-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02204-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:23:45Z","timestamp":1775035425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02204-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2204"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02204-2","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University (II2024-241-01) and has been performed under the guidelines of the Helsinki Declaration. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}